Dendreon Reports Third Quarter 2007 Financi... (38 73629 Loss from operations ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Dendreon Reports Third Quarter 2007 Financial Results

Date:11/15/2007

38 73,629

Loss from operations (19,701) (21,644) (74,523) (73,442)

Interest income 2,022 1,353 4,744 4,641

Interest expense (1,551) (452) (2,534) (1,354)

Net loss $(19,230) $(20,743) $(72,313) $(70,155)

Basic and diluted net

loss per share $(0.23) $(0.29) $(0.88) $(0.98)

Shares used in

computation of basic

and diluted net

loss per share 82,965 71,320 82,356 71,236

September 30, December 31,

2007 2006

Balance Sheet Data:

Cash and cash

equivalents $90,950 $60,964

Short-term investments 30,184 45,492

Long-term investments 17,694 14,827

Total assets 181,059 163,643

Convertible notes 85,250 -

Total stockholders' equity 64,611 125,717

SOURCE Dendreon Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007

Post Your Comments:

Breaking Biology Technology:PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision 2 The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 2 The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 3 HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2 HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3 BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2 BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3 BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4

[0] PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision [0] The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program [0] HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia [0] BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines

Other Biology Technology:Metavante Corp. will continue M&A activity 2 Directory shows high-tech growth spurt in Dane Co. 2 Directory shows high-tech growth spurt in Dane Co. 3 Directory shows high-tech growth spurt in Dane Co. 4

Metavante Corp. will continue M&A activity Rockwell software thieves plead guilty Directory shows high-tech growth spurt in Dane Co.

Breaking Biology News(10 mins):Supportive materials will help regenerate heart tissue 2 Small addition to cancer drug may make big difference 2 Small addition to cancer drug may make big difference 3 H1N1 influenza adopted novel strategy to move from birds to humans 2 H1N1 influenza adopted novel strategy to move from birds to humans 3 H1N1 influenza adopted novel strategy to move from birds to humans 4 Recession Has Women Rethinking Childbearing 58177 1 Recession Has Women Rethinking Childbearing 58177 2 Recession Has Women Rethinking Childbearing 58177 3 SPIRIT IV trial shows everolimus stent sets new standard for event free survival 58174 1 SPIRIT IV trial shows everolimus stent sets new standard for event free survival 58174 2 Workshop targets control theoretic approaches for agent based models 58171 1

[0] Supportive materials will help regenerate heart tissue [0] Small addition to cancer drug may make big difference [0] H1N1 influenza adopted novel strategy to move from birds to humans

Other Biology News:Abel to receive posthumous Ocean and Coastal Leadership award 2 How did chemical constituents essential to life arise on primitive Earth? 2

Abel to receive posthumous Ocean and Coastal Leadership award New brain cells listen before they talk How did chemical constituents essential to life arise on primitive Earth?

Biology Products:

StabilZyme HRP Conjugate Stabilizer from SurModics, Inc.Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich Conjugate Stabilizing Diluent HRP from Meridian Life Science, Inc.SA-HRP Dilution Buffer, 1L from Pierce Biotechnology, Inc.